Dr. Joseph M. Jacob, a Urologist and Chief of the Bladder Cancer Program at Upstate Medical University in Syracuse, NY has information about an innovative, non-surgical treatment approach approved by the U.S. Food and Drug Administration (FDA) for patients with Low-grade Upper tract Urothelial Cancer.
Advanced B-Cell blood cancer survivor, Bobby Hagy and Dr. Krishna Komanduri from the Sylvester Comprehensive Cancer Center where he’s Chief of Transplantation and Cellular Therapy have information about an initiative created by Novartis about an innovative type of therapy and inspire others to be hopeful about the future of cancer treatment.
